LOC401397 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.930020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.658000E-01
Normal-vs-Stage2
2.054000E-01
Normal-vs-Stage3
2.054800E-01
Normal-vs-Stage4
5.482000E-01
Stage1-vs-Stage2
9.133000E-01
Stage1-vs-Stage3
3.500600E-01
Stage1-vs-Stage4
6.849200E-01
Stage2-vs-Stage3
3.350200E-01
Stage2-vs-Stage4
6.237600E-01
Stage3-vs-Stage4
3.357400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.711780E-01
Normal-vs-AfricanAmerican
1.377370E-01
Normal-vs-Asian
6.677800E-01
Caucasian-vs-AfricanAmerican
5.784600E-01
Caucasian-vs-Asian
1.792230E-01
AfricanAmerican-vs-Asian
2.766600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.822370E-01
Normal-vs-Female
2.315000E-01
Male-vs-Female
3.681000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.059800E-01
Normal-vs-Age(41-60Yrs)
3.793400E-01
Normal-vs-Age(61-80Yrs)
1.472590E-01
Normal-vs-Age(81-100Yrs)
1.873960E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.414800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.917800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.478200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.737700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.923400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.333000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.396010E-01
Normal-vs-Daily Drinker
4.824000E-02
Normal-vs-Weekly Drinker
4.918600E-01
Normal-vs-Occasional Drinker
7.894000E-02
Normal-vs-Social Drinker
6.699400E-01
Non Drinker-vs-Daily Drinker
3.950600E-01
Non Drinker-vs-Weekly Drinker
4.147800E-01
Non Drinker-vs-Occasional Drinker
9.628600E-01
Non Drinker-vs-Social Drinker
2.702200E-02
Daily Drinker-vs-Weekly Drinker
2.185800E-01
Daily Drinker-vs-Occasional Drinker
4.132600E-01
Daily Drinker-vs-Social Drinker
2.877500E-03
Weekly Drinker-vs-Occasional Drinker
4.543200E-01
Weekly Drinker-vs-Social Drinker
3.812400E-01
Occasional Drinker-vs-Social Drinker
1.657520E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.901800E-01
Normal-vs-Grade 2
8.668000E-01
Normal-vs-Grade 3
8.686600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.340800E-01
Grade 1-vs-Grade 3
7.281800E-01
Grade 1-vs-Grade 4
8.901800E-01
Grade 2-vs-Grade 3
9.681000E-01
Grade 2-vs-Grade 4
8.668000E-01
Grade 3-vs-Grade 4
8.686600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.732400E-02
Normal-vs-NonDiabetic
2.506000E-01
Diabetic-vs-NonDiabetic
4.047500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.097960E-01
Normal-vs-NoPancreatitis
1.929620E-01
Pancreatitis-vs-NoPancreatitis
5.843600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.562560E-01
Normal-vs-N1
2.096400E-01
N0-vs-N1
7.504600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.332400E-01
Normal-vs-TP53-NonMutant
3.974600E-01
TP53-Mutant-vs-TP53-NonMutant
7.341800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
